Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 7 | 2023 | 3401 | 0.900 |
Why?
|
| Brain Neoplasms | 10 | 2023 | 8861 | 0.820 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2023 | 871 | 0.660 |
Why?
|
| Cognition Disorders | 5 | 2021 | 4043 | 0.640 |
Why?
|
| Neuropsychology | 3 | 2023 | 110 | 0.440 |
Why?
|
| Cognition | 4 | 2022 | 6770 | 0.300 |
Why?
|
| Telemedicine | 2 | 2021 | 2872 | 0.290 |
Why?
|
| Auditory Perception | 2 | 2009 | 569 | 0.260 |
Why?
|
| Verbal Learning | 1 | 2006 | 468 | 0.230 |
Why?
|
| Abdominal Cavity | 1 | 2023 | 52 | 0.220 |
Why?
|
| Brain Mapping | 4 | 2009 | 6670 | 0.210 |
Why?
|
| Blast Injuries | 2 | 2015 | 302 | 0.190 |
Why?
|
| Fatigue | 2 | 2021 | 1531 | 0.190 |
Why?
|
| Psychomotor Performance | 2 | 2008 | 1901 | 0.180 |
Why?
|
| Multiple Trauma | 1 | 2023 | 367 | 0.180 |
Why?
|
| Abdominal Injuries | 1 | 2023 | 352 | 0.180 |
Why?
|
| Temporal Lobe | 2 | 2009 | 1670 | 0.170 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 238 | 0.160 |
Why?
|
| Radiosurgery | 3 | 2018 | 1329 | 0.160 |
Why?
|
| Lung Injury | 1 | 2023 | 436 | 0.160 |
Why?
|
| Watchful Waiting | 1 | 2022 | 492 | 0.150 |
Why?
|
| Visual Perception | 1 | 2006 | 1420 | 0.150 |
Why?
|
| Quality of Life | 4 | 2022 | 12802 | 0.140 |
Why?
|
| Neurilemmoma | 1 | 2022 | 547 | 0.140 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2021 | 388 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2005 | 1423 | 0.140 |
Why?
|
| Pneumonectomy | 1 | 2023 | 1094 | 0.140 |
Why?
|
| Learning | 1 | 2005 | 1711 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2023 | 895 | 0.130 |
Why?
|
| Brain Injury, Chronic | 1 | 2015 | 68 | 0.130 |
Why?
|
| Memory | 4 | 2006 | 2174 | 0.120 |
Why?
|
| Caudate Nucleus | 1 | 2015 | 393 | 0.120 |
Why?
|
| Neuropsychological Tests | 5 | 2018 | 6994 | 0.120 |
Why?
|
| Neoplasms | 3 | 2019 | 21696 | 0.120 |
Why?
|
| Pectins | 2 | 2023 | 28 | 0.110 |
Why?
|
| Glucose Solution, Hypertonic | 1 | 1992 | 10 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 1222 | 0.100 |
Why?
|
| Scopolamine | 1 | 1992 | 99 | 0.100 |
Why?
|
| Memory Disorders | 2 | 2015 | 1186 | 0.100 |
Why?
|
| Disease Management | 2 | 2019 | 2460 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5077 | 0.100 |
Why?
|
| Humans | 32 | 2023 | 744366 | 0.090 |
Why?
|
| Orientation | 1 | 1992 | 327 | 0.090 |
Why?
|
| Discrimination Learning | 1 | 1992 | 280 | 0.090 |
Why?
|
| Pyrroles | 1 | 2015 | 1146 | 0.080 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 977 | 0.080 |
Why?
|
| Brain | 4 | 2021 | 26388 | 0.080 |
Why?
|
| Verbal Behavior | 1 | 2009 | 339 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 2943 | 0.080 |
Why?
|
| Analysis of Variance | 4 | 2017 | 6366 | 0.070 |
Why?
|
| Mutation | 2 | 2023 | 29786 | 0.070 |
Why?
|
| Indoles | 1 | 2015 | 1839 | 0.070 |
Why?
|
| Railroads | 1 | 2006 | 61 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2021 | 35425 | 0.070 |
Why?
|
| Mental Recall | 2 | 1992 | 1206 | 0.070 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2022 | 627 | 0.070 |
Why?
|
| Touch | 1 | 2008 | 306 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 19905 | 0.070 |
Why?
|
| Acoustic Stimulation | 2 | 2009 | 1216 | 0.070 |
Why?
|
| Facial Expression | 1 | 2009 | 508 | 0.060 |
Why?
|
| Solvents | 1 | 2006 | 302 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8385 | 0.060 |
Why?
|
| Veterans | 2 | 2015 | 2519 | 0.060 |
Why?
|
| Glucose | 2 | 1992 | 4398 | 0.060 |
Why?
|
| Evoked Potentials | 1 | 2009 | 1056 | 0.060 |
Why?
|
| Photic Stimulation | 2 | 2009 | 2026 | 0.060 |
Why?
|
| Pattern Recognition, Visual | 1 | 2009 | 824 | 0.060 |
Why?
|
| Afghan Campaign 2001- | 2 | 2015 | 272 | 0.060 |
Why?
|
| Swine | 2 | 2023 | 5918 | 0.050 |
Why?
|
| Hand | 1 | 2008 | 884 | 0.050 |
Why?
|
| Chest Tubes | 1 | 2023 | 150 | 0.050 |
Why?
|
| Reaction Time | 2 | 2009 | 2098 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 5709 | 0.050 |
Why?
|
| Male | 19 | 2023 | 350115 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2013 | 2029 | 0.050 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 13693 | 0.050 |
Why?
|
| Brain Diseases | 2 | 2008 | 1563 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2006 | 737 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2021 | 6598 | 0.050 |
Why?
|
| Hippocampus | 2 | 2021 | 3675 | 0.050 |
Why?
|
| Electroencephalography | 2 | 2014 | 6151 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2021 | 41005 | 0.050 |
Why?
|
| Adult | 12 | 2023 | 214052 | 0.050 |
Why?
|
| Irritable Mood | 1 | 2021 | 183 | 0.050 |
Why?
|
| Aging | 3 | 1997 | 8664 | 0.040 |
Why?
|
| Photons | 1 | 2023 | 588 | 0.040 |
Why?
|
| Confusion | 1 | 2021 | 275 | 0.040 |
Why?
|
| Aged | 8 | 2021 | 163288 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2022 | 10943 | 0.040 |
Why?
|
| Cranial Irradiation | 1 | 2021 | 401 | 0.040 |
Why?
|
| Reference Values | 1 | 2006 | 4982 | 0.040 |
Why?
|
| Neurofibromatoses | 1 | 2022 | 299 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29060 | 0.040 |
Why?
|
| Protons | 1 | 2023 | 1127 | 0.040 |
Why?
|
| Movement | 1 | 2005 | 1471 | 0.040 |
Why?
|
| Standard of Care | 1 | 2021 | 564 | 0.040 |
Why?
|
| Glycosides | 1 | 2017 | 107 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 23336 | 0.040 |
Why?
|
| Lignans | 1 | 2017 | 81 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2019 | 238 | 0.040 |
Why?
|
| Female | 15 | 2022 | 380193 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 9240 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13104 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2023 | 2879 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2023 | 1240 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 1357 | 0.030 |
Why?
|
| Occupational Exposure | 1 | 2006 | 1793 | 0.030 |
Why?
|
| Analgesics | 1 | 2022 | 1040 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8642 | 0.030 |
Why?
|
| Methylphenidate | 1 | 2019 | 473 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2019 | 726 | 0.030 |
Why?
|
| Sleep, REM | 1 | 1997 | 595 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 876 | 0.030 |
Why?
|
| Longevity | 1 | 2021 | 1071 | 0.030 |
Why?
|
| Middle Aged | 10 | 2022 | 213390 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 2960 | 0.030 |
Why?
|
| Forecasting | 2 | 2019 | 2951 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2022 | 3420 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2282 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 2887 | 0.030 |
Why?
|
| Blood Glucose | 3 | 1997 | 6254 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 1992 | 231 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2013 | 481 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2019 | 1533 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 3508 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2022 | 2267 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2014 | 931 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 2186 | 0.020 |
Why?
|
| Caregivers | 1 | 2022 | 2095 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 1148 | 0.020 |
Why?
|
| Age Factors | 2 | 2017 | 18373 | 0.020 |
Why?
|
| Time Factors | 4 | 2017 | 40075 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2022 | 63107 | 0.020 |
Why?
|
| Child | 3 | 2023 | 77709 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2015 | 1275 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1622 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2022 | 12025 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2009 | 302 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 8949 | 0.020 |
Why?
|
| Anxiety | 1 | 2022 | 4293 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 57776 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2022 | 4245 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 20824 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 12961 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 53290 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2014 | 3480 | 0.020 |
Why?
|
| Animals | 4 | 2023 | 168768 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11031 | 0.020 |
Why?
|
| Lung | 1 | 2023 | 9857 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2009 | 838 | 0.010 |
Why?
|
| Young Adult | 3 | 2017 | 56429 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10400 | 0.010 |
Why?
|
| Adolescent | 2 | 2017 | 85779 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 5692 | 0.010 |
Why?
|
| Cues | 1 | 2008 | 875 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2008 | 1767 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2009 | 1406 | 0.010 |
Why?
|
| Depression | 1 | 2022 | 7759 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12356 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8319 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25039 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2023 | 15297 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 13991 | 0.010 |
Why?
|
| Rats | 2 | 1997 | 24252 | 0.010 |
Why?
|
| Incidence | 1 | 2017 | 20952 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2014 | 21748 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 35134 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 77460 | 0.010 |
Why?
|
| Saccharin | 1 | 1992 | 20 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 72296 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 1997 | 1881 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 8300 | 0.000 |
Why?
|
| United States | 1 | 2013 | 69872 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 40559 | 0.000 |
Why?
|
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_